Libert et al., J. Exp. Med., vol. 180, pp. 1571-1575, Oct. 1994.* |
Hao et al., Biochemica et Biophysica Acta, (p) 322 (1), pp. 99-108, Sep. 1973.* |
Bouften et al., European Journal of Immunology, vol. 22, No. 10, pp. 2687-2695, Oct. 1992.* |
Edwards et al., International Journal Vox Sanguinis of Transfusion Medicine, vol. 52, pp. 53-59, 1987.* |
Weary, M., “Depyrogenation”, on PYROGENS: Endotoxins, LAL Testing, and Depyrogenation, Frederick C. Pearson, III, ed., Marcel Dekker, Inc., 203-218 (1985). |
Libert, C., et al., “Protection by α1-acid Glycoprotein Against Tumor Necrosis Factor-induced Lethality”, J. Exp. Med., 180, 1571-1575, (Oct. 1994). |
Pentel, P.R., et al., “Effects of High Dose Alpha-1-Acid Glycoprotein on Despiramine Toxicity in Rats”, Journal of Pharmacology and Experimental Therapeutics, 246 (3), 1061-1066, (1988). |
Boutten, A., et al., “α1-Acid Glycoprotein Potentiates Lipopolysaccharide-induced Secretion of Interleukin-1 β, Interleukin-6 and Tumor Necrosis Factor-α by Human Monocytes and Alveolar and Peritoneal Macrophages”, European Journal of Immunology, 22 (10), pp. 2687-2695, (Oct. 1992). |
Chen, R.F., “Removal of Fatty Acids from Serum Albumin by Charcoal Treatment”, The Journal of Biological Chemistry, 242 (2), pp. 173-181, (Jan. 25, 1967). |
Edwards, C.A., et al., “Tri (n-Butyl) Phosphate/Detergent Treatment of Licensed Therapeutic and Experimental Blood Derivatives1”, International Journal Vox Sanguinis of Transfusion Medicine, 52, pp. 53-59, (1987). |
Hao, Y., et al., “Development of Large-Scale Fractionation Methods IV. A Simple Method For the Large-Scale Preparation of α1-Acid Glycoprotein”, Biochimica Et Biophysica Acta (P) , 322 (1), pp. 99-108, (Sep. 21, 1973). |
Kistler, P., et al., “Large Scale Production of Human Plasma Fractions”, Vox Sanguinis, 7, pp. 414-424, (1962). |